Omnicom Group Inc. (OMC), the world’s second-largest advertising company, on Tuesday announced the latest third quarter results, showing slight increases in net profit and profit margin, but revenue slightly fell short of the market expectations.
Omnicom Group, is ranked as the world’s second-largest advertising company following WPP Group on the basis of sales. The company has achieved rapid growth in recent years through mergers and acquisitions of a series of digital media and emerging markets.
Omnicom Group’s third-quarter net profit was $203.9 million, equivalent to 74 cents per share, slightly higher than $203.7 million, equivalent to 72 cents per share in the same period last year; the reported quarter revenue increased 0.8% from a year ago to $3.41 billion.
Analysts had generally expected Omnicom Group’s net profit would be 72 cents per share on revenue of approximately $3.42 billion for the third quarter. The company also reported the third quarter operating margin increased from last year same period’s 11% to 11.4%; domestic revenue increased 3.2% year-over-year, international revenue was down 1.7% from a year ago. OMC stock price lost over 2.6% in the morning trading session.
State Street Corporation (STT) on Tuesday issued its second quarter earnings report, saying the second quarter profit of $654 million, or about $1.36 per share. The company reported a profit of $1.10 per share for the same period of the prior year.
The earnings report also showed that the company’s total operating income of $2.36 billion for the third quarter, down 3% from last year same period. The second quarter operating profit was 99 cents per share. Market analysts on average had expected the company would post earnings of 96 cents per share on revenue of $2.38 billion for this quarter. STT stock price surged nearly 4.5% Tuesday morning.
Johnson & Johnson (JNJ) released the latest quarterly financial results on Tuesday, showing its third-quarter net profit fell 7%, due to the rising costs of R&D had offset the growth in sales of drugs and medical equipments, but the adjusted results were better than the consensus estimates.
The company posted net profit from a year earlier’s $3.2 billion, or $ 1.15 per share, to $2.97 billion, or $1.05 per share for the reported quarter. Excluding one-time items, the company posted adjusted earnings of $3.5 billion, or $1.25 per share, beating the consensus estimate of $1.21 per share. The third quarter revenue rose 6.5% to $17.05 billion, slightly higher than the average analyst estimate of $17.01 billion.
Johnson & Johnson also raised the ceiling of its full-year earnings forecast, expected earnings of $5-$5.07 per share.
JNJ stock price gained 1.20% in the morning trading on Tuesday.